Medication hubs

GLP-1 medication hubs

One page per medication with the facts that matter for nutrition: protein targets, electrolyte needs, side-effect playbooks, and the supplements worth taking. Covers Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, and tirzepatide.

GLP-1 receptor agonist

Ozempic

Ozempic is once-weekly semaglutide, a GLP-1 receptor agonist that slows gastric emptying and reduces appetite. Because food intake typically falls 30–40%, the highest-value support is protein (0.7–1.0 g per pound of goal weight), electrolytes, magnesium glycinate at night, 5–10 g of soluble fiber, and a B-complex with vitamin D. Supplements do not change how Ozempic works — they replace the nutrients smaller meals no longer supply.

Open hub
GLP-1 receptor agonist

Wegovy

Wegovy is semaglutide dosed for weight management, titrated to 2.4 mg weekly. At maintenance dose most users eat 35–50% less, so protein, electrolytes, magnesium, fiber, and a daily multivitamin matter more than on lower diabetes doses. Prioritise protein and resistance training to limit lean-mass loss, and step up electrolytes during each titration increase.

Open hub
Dual GIP/GLP-1 receptor agonist

Mounjaro

Mounjaro is once-weekly tirzepatide, a dual GIP/GLP-1 receptor agonist. Appetite suppression is generally stronger than on semaglutide, so protein (0.8–1.0 g per pound of goal weight), electrolytes, magnesium glycinate, a gut-health blend, and vitamin D3/K2 are the highest-value supports. Nothing you take makes tirzepatide work better — supplements exist to protect muscle, energy, and digestion while you eat less.

Open hub
Dual GIP/GLP-1 receptor agonist

Zepbound

Zepbound is tirzepatide approved for chronic weight management. Because average weight loss is the highest of any current GLP-1 medication, muscle protection is the top priority: 0.8–1.0 g of protein per pound of goal weight plus resistance training 2–3 times per week. Electrolytes, magnesium glycinate, soluble fiber, and vitamin D3/K2 handle hydration, sleep, digestion, and bone health.

Open hub
GLP-1 receptor agonist

Semaglutide

Semaglutide is the GLP-1 receptor agonist sold as Ozempic and Rybelsus for type 2 diabetes and Wegovy for weight management. The nutrition strategy is the same across brands: 0.7–1.0 g of protein per pound of goal weight, daily electrolytes, 200–400 mg magnesium glycinate at night, 5–10 g soluble fiber, and a B-complex with vitamin D3/K2. Oral semaglutide (Rybelsus) additionally requires a 30-minute fasted window before food or supplements.

Open hub
Dual GIP/GLP-1 receptor agonist

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist sold as Mounjaro for type 2 diabetes and Zepbound for weight management. It suppresses appetite more strongly than semaglutide, so protein at 0.8–1.0 g per pound of goal weight, daily electrolytes, magnesium glycinate, a gut-health blend, and vitamin D3/K2 are the practical priorities. Resistance training two to three times weekly is as important as any supplement for preserving lean mass.

Open hub